BioRN

What BioRN does

BioRN Network e.V. is a non-profit life science cluster organization founded in 1996 and headquartered in Heidelberg, Germany (BioRN Cluster Management GmbH operates as the management entity). It acts as a translational ecosystem broker for the Rhine-Neckar region, connecting academic and research institutions (DKFZ, EMBL, Heidelberg University and others), global pharmaceutical companies (AbbVie, Boehringer Ingelheim, GSK, J&J, Lilly, Roche, BMS, Bayer, Merck, Sanofi, Janssen), SMEs, startups, investors, and public-sector stakeholders. As of 2026 the network comprises more than 180 institutional members, and the wider Rhine-Neckar region that BioRN represents accounts for roughly 1,200 life science companies, 70,000+ industry employees, 14,000 scientific staff, 70 ongoing clinical trials, and 17,500+ publications per year.

BioRN's service portfolio includes bioRN Scout (innovation scouting for partnering, investments, and licensing), Softlanding (market-entry support for foreign startups and SMEs into Germany/Europe), Startup Support, and the physical BioLabs Heidelberg incubator launched in April 2023, which BioRN initiated as part of the global BioLabs network. It also operates the beLAB2122 BRIDGE public-private partnership (established 2021 with Evotec and Bristol Myers Squibb, deploying a €20M fund) for preclinical drug-discovery translation, and runs a calendar of flagship events: life – the biomedical convention (annual, 500+ participants), smartLabs Summit, BioRN Life Science Week (including Industry-Academia-Day and the Annual Conference), and the Life Science Investors' Day, which convenes ~90 international investors with ~24 pitching European startups.

BioRN's business model rests on three recurring streams: institutional membership subscriptions across academic, pharma, SME, and government tiers; event revenue from sponsorships, exhibitor fees, and ticket sales (with member discounts such as 15% on conferences and 60% on the first 100 tickets to bio:cap europe); and fee-based services spanning innovation scouting, market expansion, and startup support. Distribution is community-led and direct: a small core management team (11-50 employees) engages members via events, an email newsletter, LinkedIn/X/Mastodon/Bluesky/YouTube channels, the 'life' magazine (in collaboration with European Biotechnology), and representation at international venues such as the BIO Europe German Pavilion. The organization is governed by an Executive Board chaired by Dr. Gitte Neubauer with Dr. Julia Schaft as Managing Director.

Name

BioRN

Legal name

BioRN Network e.V.

Website

https://biorn.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

BioRN is a non-profit life science cluster founded in 1996 in Heidelberg, Germany, connecting 180+ institutional members across academia, global pharma, SMEs, and government in the Rhine-Neckar region through membership services, flagship events, innovation scouting, and the BioLabs Heidelberg incubator.

Ownership category

akta.pro rank

Product category

Life Science Cluster Management

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF)

akta.pro secondary industry

Life Sciences & Biotechnology Congresses (THAHAJAB)

Keywords

• Life science cluster management
• Innovation scouting services
• Startup incubation support
• Academic industry collaboration
• Biomedical ecosystem development

Headquarters

HQ city

Heidelberg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Institutional Membership: BioRN operates a membership program with institutional members including academic institutions, pharmaceutical companies, SMEs, and government organizations. The membership provides access to networking, services, discounts, and the translational ecosystem.
2. Event Organization: BioRN organizes major events including the annual Life Science Week, Annual Conference, Life - the biomedical convention, and various workshops and networking events. These events generate revenue through sponsorships, exhibitor fees, and ticket sales while serving the ecosystem.
3. Services: BioRN offers services including bioRN Scout (innovation scouting), Softlanding (market expansion support), and Startup Support. These services are provided to members and external parties seeking to engage with the Rhine-Neckar life science ecosystem.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels10 records

Core offering

BioRN is a non-profit life science cluster organization that fosters health innovations by creating a translational ecosystem connecting academic institutions, pharmaceutical companies, SMEs, and government organizations in the Rhine-Neckar region. It delivers value through an institutional membership program, innovation scouting (bioRN Scout), market expansion support (Softlanding), startup support services, and flagship networking events including the annual life – the biomedical convention and Life Science Investors' Day. It also initiated the BioLabs Heidelberg incubator and manages the beLAB2122 BRIDGE €20M public-private fund for preclinical drug discovery.

Product overview

BioRN (Life Science Cluster Rhine-Neckar) is a science and industry innovation cluster organization based in Heidelberg, Germany, established in 1996. Rather than a unified software platform, BioRN offers a portfolio of service offerings including bioRN Scout (innovation scouting for partnering, investments and licensing), Softlanding (market entry support for foreign startups), and Startup Support. The organization also operates flagship events including life – the biomedical convention (annual), smartLabs Summit, Life Science Investors' Day, and Industry-Academia-Day. BioRN is the initiator of Biolabs Heidelberg, a shared laboratory incubator for biotech startups, and manages the beLAB2122 BRIDGE public-private partnership for preclinical drug development. BioRN serves approximately 150 institutional members including academic institutions, pharmaceutical companies, and SMEs in the Rhine-Neckar life science ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

• life - the biomedical convention: BioRN's flagship annual convention and conference focused on biomedical innovation and personalized medicine.
• smartLabs Summit
• Life Science Investors' Day
• bioRN Life Science Week

Products and services

• bioRN Scout Innovation scouting service providing tailored scouting for partnering, investments and licensing needs, offered to members and external parties engaging with the Rhine-Neckar life science ecosystem.
• Softlanding Service enabling local and foreign startups and middle-sized entrepreneurs to expand their business into the German, European, and global markets through the Rhine-Neckar network.
• Startup Support Service empowering startups by providing resources including time support, mentorship, and connections to the BioRN ecosystem.
• life – the biomedical convention Flagship annual convention of the bioRN Life Science Cluster, marking the organization's anniversary and connecting the life science ecosystem with 500+ participants in 2026.
• smartLabs Summit Annual summit organized by bioRN focusing on smart laboratory solutions and innovations in life sciences.
• Life Science Investors' Day Annual networking event where European startups in medtech, biotech, and digital health present innovations to 90 international investors.
• Industry-Academia-Day Exclusive gathering for bioRN pharma partners featuring live presentations of hand-selected oncology projects from early-stage academic research.
• BioLabs Heidelberg Fully equipped incubator providing on-demand wet laboratories and office spaces to early-stage life science startups, with direct access to a network of industry partners and investors. Part of the global BioLabs network.
• beLAB2122 BRIDGE Public-private partnership between academic institutions of the Rhine-Neckar region, Evotec, and Bristol Myers Squibb for preclinical development of academic drug discovery projects, with a €20M fund aimed at creating spinout companies.

Quantifiable outcome

• 500+ participants at flagship annual convention (life - the biomedical convention 2026)
• +3 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

13 partnerships are on record, tiered core and minor.

• Bristol Myers SquibbcoreStrategic or Co-development Partner · 1 January 2021BMS is a partner in the beLAB2122 BRIDGE public-private partnership, contributing to a €20M fund for preclinical development of academic drug discovery projects. The partnership identifies, funds and executes novel disease-modifying therapeutic projects with the goal of developing them to new spinout companies.
• EvoteccoreStrategic or Co-development Partner · 1 January 2021Evotec established beLAB2122 BRIDGE in 2021, a €20M public-private partnership with academic institutions of the Rhine-Neckar region, BMS, and BioRN to identify and fund preclinical drug discovery projects with potential for spinout creation.
• Biolabs HeidelbergcoreStrategic or Co-development PartnerBioRN is the initiator of Biolabs Heidelberg, a fully equipped incubator providing wet laboratories and office spaces to early-stage life science startups with direct access to industry partners and investors. Biolabs Heidelberg is part of the global BioLabs network.
• DKFZ (German Cancer Research Center)coreStrategic or Co-development PartnerDKFZ is a key academic partner in the beLAB2122 BRIDGE and a major research institution within the BioRN ecosystem, contributing to translational research initiatives.
• EMBL (European Molecular Biology Laboratory)coreStrategic or Co-development PartnerEMBL is a founding academic partner in the BioRN ecosystem and in the beLAB2122 BRIDGE initiative, contributing world-class research capabilities to the regional translational ecosystem.
• Heidelberg UniversitycoreStrategic or Co-development PartnerMajor academic partner in the BioRN cluster and beLAB2122 BRIDGE, providing research excellence and talent pipeline to the regional life science ecosystem.
• Goethe University FrankfurtminorStrategic or Co-development PartnerPartner institution in the beLAB2122 BRIDGE collaboration, extending the academic network beyond the Rhine-Neckar region.
• University of TübingenminorStrategic or Co-development PartnerAcademic partner in the beLAB2122 BRIDGE collaboration for preclinical drug development.
• Life Science Accelerator Baden-WürttembergcoreStrategic or Co-development PartnerCo-organizer of the annual Life Science Investors' Day event, bringing together European startups with international investors in the life science sector.
• Heidelberg Startup PartnerscoreStrategic or Co-development PartnerCo-organizer of Life Science Investors' Day, supporting startup ecosystem development in Heidelberg.
• Biopro Baden-WürttembergminorStrategic or Co-development PartnerSupporting partner of Life Science Investors' Day, contributing to the regional biotech ecosystem development.
• European Commission / EU ParliamentminorStrategic or Co-development PartnerBioRN hosts high-level roundtables with EU policymakers on biotechnology competitiveness, including discussions on the European Biotech Act with MEP Hildegard Bentele.
• BMBF (Federal Ministry of Education and Research, Germany)coreStrategic or Co-development PartnerBMBF organizes the German Pavilion at international events like BIO Europe where BioRN represents the life science ecosystem, and provides funding programs like the market exploration delegations.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• BioM Biotech Cluster Development GmbH: Munich-based non-profit life science cluster management organization coordinating Bavaria's biotech ecosystem, with analogous services (networking, scouting, events) and a similar member-based business model.
• Flanders.bio: Belgian non-profit life sciences cluster representing biotech, pharma, and medtech companies in Flanders; mirrors BioRN's member-driven, networking- and event-centric model in another major European biotech hub.
• One Nucleus: UK-based life sciences and genomics membership organization for the Cambridge/London corridor; comparable in providing networking, partnering events, and investor introductions to a dense academic-pharma ecosystem.
• Medicon Valley Alliance: Danish-Swedish cross-border life science cluster organization in the Øresund region; comparable in fostering industry-academia collaboration and cross-border innovation across pharma and biotech.
• BioCat: Catalonia's biotechnology and biomedicine cluster organization based in Barcelona; comparable in driving translational research, startup support, and international promotion of a regional life science hub.
• Swiss Biotech Association: Swiss national industry association representing biotech SMEs, large companies, and academic institutions; provides networking, events, and advocacy analogous to BioRN's cluster facilitation role.

Regional players

• BIOPRO Baden-Württemberg GmbH: Stuttgart-headquartered state-level life sciences agency that supports biotech, medtech, and pharma innovation in Baden-Württemberg; directly comparable in mission and is also a BioRN co-organizer for Life Science Investors' Day.
• Life Science Nord Management GmbH: Cluster organization for the Hamburg/Schleswig-Holstein life science sector covering pharma, biotech, and medtech; comparable cluster-management model with member services and event programming.
• BioRegio STERN Management GmbH: Regional biotech cluster in the Stuttgart/Neckar-Alb/District area promoting start-ups, academic-industry transfer, and investor relations — directly analogous to BioRN's translational role in a neighboring German region.
• ScanBalt: Macro-region network connecting life science clusters across the Baltic Sea region; an ecosystem-level convening organization comparable to BioRN in scale and translational mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BioRNCluster
• YouTubeyoutube.com/user/TheBioRNcluster
• LinkedInlinkedin.com/company/biorn-cluster-management-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioRN